Figure 1From: Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids CONSORT/patient flow diagram. *One patient was not randomised but received study treatment (placebo) in error. This patient was not included in the ITT population. BD: twice-daily; ITT: intent-to-treat; OD: once-daily; SAL: salmeterol; VI: vilanterol.Back to article page